| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/22/2014 | US8703712 Targeting cancer stem cells with DR5 agonists |
| 04/22/2014 | US8703705 Modified factor VIII peptides |
| 04/22/2014 | US8703695 Biologically active peptides and their new uses |
| 04/22/2014 | US8703480 Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and target cells |
| 04/22/2014 | US8703471 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 04/22/2014 | US8703469 Baculoviruses with enhanced virion production and a method for the production of baculoviruses |
| 04/22/2014 | US8703468 Porcine circovirus type 2B isolate and uses thereof |
| 04/22/2014 | US8703436 Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 04/22/2014 | US8703427 Biological materials and uses thereof |
| 04/22/2014 | US8703154 Adjuvant for the preparation of vaccine compositions intended for the prevention of coccidiosis |
| 04/22/2014 | US8703153 Salmonella vectored vaccines against Chlamydia and methods of use |
| 04/22/2014 | US8703152 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 04/22/2014 | US8703151 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 04/22/2014 | US8703150 Methods of using Bacillus anthracis protective antigen sequences for vaccination |
| 04/22/2014 | US8703149 HCV coreceptor and methods of use thereof |
| 04/22/2014 | US8703148 Immunogenic composition |
| 04/22/2014 | US8703147 Methods and compositions for treating and preventing malaria (2) |
| 04/22/2014 | US8703146 Toll-like receptor 5 ligands and methods of use |
| 04/22/2014 | US8703145 Materials and methods for immunizing against FIV infection |
| 04/22/2014 | US8703144 Allergen peptide fragments and use thereof for treatment of dust mite allergies |
| 04/22/2014 | US8703143 Antibodies of the ED-B domain of fibronectin, their construction and uses |
| 04/22/2014 | US8703142 Methods to bypass CD4+ cells in the induction of an immune response |
| 04/22/2014 | US8703141 Method for treating Crohn's disease by administering an anti-IL-12 antibody |
| 04/22/2014 | US8703140 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 04/22/2014 | US8703139 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 04/22/2014 | US8703138 Treatment of inflammatory diseases by inhibiting cold-inducible RNA-binding protein (CIRP) |
| 04/22/2014 | US8703137 Treatment of tauopathies |
| 04/22/2014 | US8703136 Complement inhibition for improved nerve regeneration |
| 04/22/2014 | US8703135 Biological materials related to c-Met |
| 04/22/2014 | US8703134 Targeted cryptosporidium biocides |
| 04/22/2014 | US8703133 Antibody variants |
| 04/22/2014 | US8703132 Bispecific, tetravalent antigen binding proteins |
| 04/22/2014 | US8703131 Nanobodies against tumor necrosis factor-alpha |
| 04/22/2014 | US8703130 Bispecific anti-VEGF/anti-ANG-2 antibodies |
| 04/22/2014 | US8703129 Antibodies against extended type 1 chain antigens, derivatives thereof and use |
| 04/22/2014 | US8703128 Methods of modulating TGFβ signaling |
| 04/22/2014 | US8703127 Methods and materials for the diagnosis of prostate cancers |
| 04/22/2014 | US8703126 Reduced-viscosity concentrated protein formulations |
| 04/22/2014 | US8703125 Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders |
| 04/22/2014 | US8703124 Combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
| 04/22/2014 | CA2753700C Anti-rhesus d monoclonal antibody |
| 04/22/2014 | CA2751655C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 04/22/2014 | CA2703279C Antibody purification by cation exchange chromatography |
| 04/22/2014 | CA2609234C Anti-il2 antibodies |
| 04/22/2014 | CA2595906C Libraries and methods for isolating antibodies |
| 04/22/2014 | CA2572985C Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| 04/22/2014 | CA2572015C Fc-interferon-beta fusion proteins |
| 04/22/2014 | CA2552392C Apicomplex vaccine strains of a family of sarcocystidae |
| 04/22/2014 | CA2548135C Synthetic hla binding peptide analogues and uses thereof |
| 04/22/2014 | CA2527795C Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines |
| 04/22/2014 | CA2519258C Construct comprising region recognized by antibody against von willebrand factor-specific cleaving protease |
| 04/22/2014 | CA2496508C Cancer therapy using beta glucan and antibodies |
| 04/22/2014 | CA2469785C Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 04/22/2014 | CA2398998C Cd40-binding apc-activating molecules |
| 04/22/2014 | CA2394357C Modified leukotoxin gene and protein |
| 04/22/2014 | CA2333921C Verotoxin b subunit for immunization |
| 04/17/2014 | WO2014059296A1 An attenuated ehec and clostridial toxins tcda and tcdb based vaccine for clostridium difficil associated disease (cdad) |
| 04/17/2014 | WO2014059251A1 Enhancement of the immune response |
| 04/17/2014 | WO2014059197A1 Methods and compositions for diagnosing and treating hyposmia |
| 04/17/2014 | WO2014059147A1 Methods and composition for treatment of th2-mediated and th17-mediated diseases |
| 04/17/2014 | WO2014059028A1 Anti-c16orf54 antibodies and methods of use thereof |
| 04/17/2014 | WO2014058985A1 High-throughput assays for enzyme inhibitors and peptide inhibitors against hiv-1 and methods for using them |
| 04/17/2014 | WO2014058875A2 Combination therapies and uses for treatment of demyelinating disorders |
| 04/17/2014 | WO2014058394A1 Method of prognosis and stratification of ovarian cancer |
| 04/17/2014 | WO2014057687A1 Antibody-drug conjugate |
| 04/17/2014 | WO2014057132A1 Non-cross-linked acellular pertussis antigens for use in combination vaccines |
| 04/17/2014 | WO2014057122A1 Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
| 04/17/2014 | WO2014057118A1 Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
| 04/17/2014 | WO2014057115A1 Pyrrolobenzodiazepine-anti-her2 antibody conjugates |
| 04/17/2014 | WO2014056934A1 Modulator of quinolinic acid for use in the treatment of a neuropathological disease |
| 04/17/2014 | WO2014056816A1 COMBINATION OF AN Aβ ANTIBODY AND A BACE INHIBITOR |
| 04/17/2014 | WO2014056333A1 Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor |
| 04/17/2014 | WO2014031697A3 COMPOSITIONS AND METHODS RELATED TO DISEASES ASSOCIATED WITH DEPOSITS OF AMYLOID, TAU, AND α-SYNUCLEIN |
| 04/17/2014 | WO2014030052A3 Compositions comprising an antibody and camostat mesylate (cm) |
| 04/17/2014 | WO2014030049A3 Compositions comprising a single variable domain and camostat mesylate (cm) |
| 04/17/2014 | WO2014025771A3 Methods and compositions for inactivating enveloped viruses |
| 04/17/2014 | WO2014025546A3 Anti-dengue virus antibodies and uses thereof |
| 04/17/2014 | WO2014022475A3 Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers |
| 04/17/2014 | WO2014020205A3 Improved anti-hiv immunogens |
| 04/17/2014 | WO2014009738A3 Treatment of muscular dystrophy |
| 04/17/2014 | WO2014009209A3 Immunoregulatory vaccine |
| 04/17/2014 | WO2014006025A3 Marker of pathogenicity in salmonella |
| 04/17/2014 | WO2013158818A3 Vaccines and methods to treat lyme disease in dogs |
| 04/17/2014 | WO2013130102A3 Dual ox40 agonist/il-2 cancer therapy methods |
| 04/17/2014 | WO2013110064A9 Fusion protein for enhancing immunogenicity of bacterial antigen/immunogen |
| 04/17/2014 | WO2013109279A3 Stabilization of the anti-cd20 antibody rituximab |
| 04/17/2014 | WO2012149525A3 Ureaplasma vaccine and antibody for prevention and treatment of human, animal and cell culture infection |
| 04/17/2014 | US20140107391 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 04/17/2014 | US20140107227 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 04/17/2014 | US20140106455 Process for preparing vaccine composition |
| 04/17/2014 | US20140105998 Treatment of diseases |
| 04/17/2014 | US20140105992 Vaccine |
| 04/17/2014 | US20140105980 Methods and compositions for treating multiple sclerosis and related disorders |
| 04/17/2014 | US20140105961 Immunomodulation using spores and pollen grains |
| 04/17/2014 | US20140105934 Method for enhancing immune response in the treatment of infectious and malignant diseases |
| 04/17/2014 | US20140105933 Methods for assessing cancer recurrence |
| 04/17/2014 | US20140105930 Bovine vaccines and methods |
| 04/17/2014 | US20140105927 Immunogenic composition |
| 04/17/2014 | US20140105926 Immunogenic composition |
| 04/17/2014 | US20140105924 Immunogenic HPV L2-Containing VLPs and Related Compositions, Constructs, and Therapeutic Methods |